Source: Eur Respir Monogr 2016; 71: 196-217
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vincent Cottin, Claudia Valenzuela. Pharmacological management. Eur Respir Monogr 2016; 71: 196-217

Member's Comments

No comment yet.

Related content which might interest you: Pharmacological treatment Source: International Congress 2017 – Latest GOLD update Year: 2017 Pharmacological treatments Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Pharmacological approach Source: Annual Congress 2006 - The critically ill patient: chronic obstructive lung disease Year: 2006 Pharmacological prevention of VAP Source: Annual Congress 2003 - The diagnosis and prevention of ventilator-associated pneumonia Year: 2003 Pharmacological options for the treatment of COPD: present and future Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 Pharmacological and Non-pharmacological therapies that modulare lung function decline Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today Year: 2021 Pharmacological treatment & current controversies in asthma Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020 AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Therapeutic and management implications Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited Year: 2010 Pharmacological option for hyperinflation Source: International Congress 2014 – Severe lung hyperinflation: troubles and solutions Year: 2014